NEW YORK (GenomeWeb) – Theranostics Health today announced an agreement with Avera Health to expand research and commercial collaborations on the firm's TheraLink Assay.

The proteomic panel measures the activation of several drug targets and biomarkers associated with commonly prescribed cancer therapies to monitor treatment response.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.